Related Experiment Video
Updated: Jul 11, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Cryptococcal meningitis
Lillian Tugume1, Kenneth Ssebambulidde2,3, John Kasibante2
1Infectious Diseases Institute, Makerere University, Kampala, Uganda. ltugume@idi.co.ug.
Abstract:
Cryptococcus neoformans and Cryptococcus gattii species complexes cause meningoencephalitis with high fatality rates and considerable morbidity, particularly in persons with deficient T cell-mediated immunity, most commonly affecting people living with HIV. Whereas the global incidence of HIV-associated cryptococcal meningitis (HIV-CM) has decreased over the past decade, cryptococcosis still accounts for one in five AIDS-related deaths globally due to the persistent burden of advanced HIV disease. Moreover, mortality remains high (~50%) in low-resource settings. The armamentarium to decrease cryptococcosis-associated mortality is expanding: cryptococcal antigen screening in the serum and pre-emptive azole therapy for cryptococcal antigenaemia are well established, whereas enhanced pre-emptive combination treatment regimens to improve survival of persons with cryptococcal antigenaemia are in clinical trials. Short courses (≤7 days) of amphotericin-based therapy combined with flucytosine are currently the preferred options for induction therapy of cryptococcal meningitis. Whether short-course induction regimens improve long-term morbidity such as depression, reduced neurocognitive performance and physical disability among survivors is the subject of further study. Here, we discuss underlying immunology, changing epidemiology, and updates on the management of cryptococcal meningitis with emphasis on HIV-associated disease.
Insights
Cryptococcal meningitis, especially in people with HIV, remains a deadly threat. New treatments and diagnostics are improving outcomes, but long-term effects require further study.
Area of Science:
- Mycology
- Infectious Diseases
- Immunology
Background:
- Cryptococcus neoformans and Cryptococcus gattii cause life-threatening meningoencephalitis, particularly in immunocompromised individuals, notably people living with HIV.
- Despite a decline in HIV-associated cryptococcal meningitis (HIV-CM), it remains a leading cause of AIDS-related deaths globally, with high mortality rates (~50%) in resource-limited settings.
- Advanced HIV disease contributes to the persistent burden of cryptococcosis.
Purpose of the Study:
- To review the immunology, epidemiology, and current management strategies for cryptococcal meningitis, with a focus on HIV-associated cases.
- To highlight advancements in diagnostics and therapeutics for cryptococcosis.
- To discuss ongoing research into the long-term morbidity of cryptococcal meningitis survivors.
Main Methods:
- Review of current literature on cryptococcal meningitis management.
- Analysis of epidemiological trends in HIV-associated cryptococcosis.
- Discussion of emerging treatment modalities and diagnostic tools.
Main Results:
- Cryptococcal antigen screening and pre-emptive azole therapy are established interventions.
- Enhanced pre-emptive combination treatments are under investigation to improve survival.
- Short-course (≤7 days) amphotericin-based therapy with flucytosine is the current standard for induction therapy.
Conclusions:
- While mortality from HIV-CM is decreasing, it remains a significant global health challenge.
- New diagnostic and therapeutic strategies are expanding the options for managing cryptococcosis.
- Further research is needed to understand and mitigate long-term neurological and psychological sequelae in survivors of cryptococcal meningitis.
Related Concept Videos
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Basidiomycota
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

